239 related articles for article (PubMed ID: 12574409)
1. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons.
Durham PL; Russo AF
J Neurosci; 2003 Feb; 23(3):807-15. PubMed ID: 12574409
[TBL] [Abstract][Full Text] [Related]
2. Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.
Durham PL; Sharma RV; Russo AF
J Neurosci; 1997 Dec; 17(24):9545-53. PubMed ID: 9391009
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.
Bellamy J; Bowen EJ; Russo AF; Durham PL
Eur J Neurosci; 2006 Apr; 23(8):2057-66. PubMed ID: 16630053
[TBL] [Abstract][Full Text] [Related]
4. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug.
Durham PL; Russo AF
J Neurosci; 1999 May; 19(9):3423-9. PubMed ID: 10212302
[TBL] [Abstract][Full Text] [Related]
5. Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons.
Durham PL; Dong PX; Belasco KT; Kasperski J; Gierasch WW; Edvinsson L; Heistad DD; Faraci FM; Russo AF
Brain Res; 2004 Jan; 997(1):103-10. PubMed ID: 14715155
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal.
Durham PL; Russo AF
Mol Endocrinol; 2000 Oct; 14(10):1570-82. PubMed ID: 11043573
[TBL] [Abstract][Full Text] [Related]
7. Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons.
Park KY; Russo AF
J Biol Chem; 2008 Feb; 283(9):5441-51. PubMed ID: 18167349
[TBL] [Abstract][Full Text] [Related]
8. [The pharmacological mechanism of gastrodin on calcitonin gene-related peptide of cultured rat trigeminal ganglion].
Luo GG; Fan WJ; Yuan XY; Yuan BB; Lü SM; Cao YX; Xu CB
Yao Xue Xue Bao; 2011 Dec; 46(12):1451-6. PubMed ID: 22375417
[TBL] [Abstract][Full Text] [Related]
9. Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.
Durham PL; Masterson CG
Headache; 2013 Jan; 53(1):67-80. PubMed ID: 23095108
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-activated protein kinase pathways are involved in the upregulation of calcitonin gene-related peptide of rat trigeminal ganglion after organ culture.
Lei L; Yuan X; Wang S; Zhang F; Han Y; Ning Q; Luo G; Lu S
J Mol Neurosci; 2012 Sep; 48(1):53-65. PubMed ID: 22528462
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain.
Ceruti S; Villa G; Fumagalli M; Colombo L; Magni G; Zanardelli M; Fabbretti E; Verderio C; van den Maagdenberg AM; Nistri A; Abbracchio MP
J Neurosci; 2011 Mar; 31(10):3638-49. PubMed ID: 21389219
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer.
Durham PL; Russo AF
Mol Endocrinol; 1998 Jul; 12(7):1002-9. PubMed ID: 9658404
[TBL] [Abstract][Full Text] [Related]
13. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology.
Thalakoti S; Patil VV; Damodaram S; Vause CV; Langford LE; Freeman SE; Durham PL
Headache; 2007; 47(7):1008-23; discussion 24-5. PubMed ID: 17635592
[TBL] [Abstract][Full Text] [Related]
14. CGRP stimulation of iNOS and NO release from trigeminal ganglion glial cells involves mitogen-activated protein kinase pathways.
Vause CV; Durham PL
J Neurochem; 2009 Aug; 110(3):811-21. PubMed ID: 19457095
[TBL] [Abstract][Full Text] [Related]
15. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system.
Limmroth V; Katsarava Z; Liedert B; Guehring H; Schmitz K; Diener HC; Michel MC
Pain; 2001 May; 92(1-2):101-6. PubMed ID: 11323131
[TBL] [Abstract][Full Text] [Related]
16. New insights into the molecular actions of serotonergic antimigraine drugs.
Durham PL; Russo AF
Pharmacol Ther; 2002; 94(1-2):77-92. PubMed ID: 12191595
[TBL] [Abstract][Full Text] [Related]
17. IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.
Neeb L; Hellen P; Boehnke C; Hoffmann J; Schuh-Hofer S; Dirnagl U; Reuter U
PLoS One; 2011 Mar; 6(3):e17360. PubMed ID: 21394197
[TBL] [Abstract][Full Text] [Related]
18. Calcitonin gene-related peptide (CGRP) and migraine.
Durham PL
Headache; 2006 Jun; 46 Suppl 1(Suppl 1):S3-8. PubMed ID: 16927957
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion.
Zhang Z; Winborn CS; Marquez de Prado B; Russo AF
J Neurosci; 2007 Mar; 27(10):2693-703. PubMed ID: 17344407
[TBL] [Abstract][Full Text] [Related]
20. Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor.
Freeland K; Liu YZ; Latchman DS
Biochem J; 2000 Jan; 345 Pt 2(Pt 2):233-8. PubMed ID: 10620499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
